Quality of Nursing Home Environments
Actavis and adamas pharmaceuticals, inc., announced that the u.s. Food and drug administration has approved the new drug application for namzaric™ for the treatment of moderate to severe dementia of the alzheimer’s type in patients stabilized on memantine hydrochloride and donepezil hydrochloride.
A man-made form of insulin delivered by nasal spray may improve working memory and other mental capabilities in adults with mild cognitive impairment (mci) and alzheimer’s dementia (ad), according to a pilot study published in the journal of alzheimer’s disease.
Funding Alzheimer’s Research
The Costs of Alzheimer’s Caregiving